Search results
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 20 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Some 700,000 Brits To Get Free Covid-19 Booster Shots This Week
Forbes· 3 days agoStarting Monday, the elderly and those with weakened immune systems will be able to get a shot free...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 1 day agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Vaccine Safety and DMT for Highly Active MS: New Data
Medscape· 10 hours agoMany clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 1 day agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Rival Covid-19 jab developers face off in High Court patent trial
Press Association News via AOL· 1 day agoHow the Moderna and Pfizer/BioNTech vaccines work is by targeting the spike protein in Covid-19 ...
Watchdog group: FBI records indicate Fauci’s agency funded gain-of-function research at Wuhan lab
World Tribune· 22 hours agoA government watchdog group announced on April 19 that it received records from the FBI in a Freedom...
UK virtually ends free vaccines as COVID-19 continues to spread
World Socialist Web Site· 3 days agoMore than four years since the UK reported its initial case of COVID-19, the virus continues to...
COVID-19 booster immunity lasts much longer than primary series alone, study shows
Medical Xpress· 6 days agoThe study used Canadian vaccine data collected from individuals living in long-term care, as well as frontline health-care workers working in long-term care and hospitals.
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 1 day agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people